1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.

Sun Pharma gets US subpoena over generic drugs pricing

Discussion in 'Stock Market Discussions' started by capitalstars05, May 30, 2016.

  1. capitalstars05

    capitalstars05 New Member

    Sep 26, 2014
    Likes Received:
    Sun Pharma gets US subpoena over generic drugs pricing – Sentimental Negative for Sun; the inquiry is unlikely to have any adverse impact on the consolidated operations or consolidated financial results of the company.
    The US Department of Justice (DoJ) has subpoenaed Sun Pharmaceutical Industries seeking information about the pricing and marketing of the generic drugs it sells in the United States.
    The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors.

    Our Some Best Services Read it Here
    Domestic Forex Intraday,
    Financial Advisory Indore, Stock Advisory Indore,

    Commodity Market Tips, MCX Tips,

    Crude oil tips, Sgx Nifty,

    Nifty Futures Tips
    CapitalStars Financial Research Financial Advisory Services
    www.capitalstars.com | T:+91-731-6790000,6669900

Share This Page